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There are sex differences in the progression of drug addiction, relapse, and response to
therapies. Because biological factors participate in these differences, they should be con-
sidered when using biomarkers for addiction. In the current study, we evaluated the sex
differences in psychiatric comorbidity and the concentrations of plasma mediators that have
been reported to be affected by cocaine. Fifty-five abstinent cocaine-addicted subjects diag-
nosed with lifetime cocaine use disorders (40 men and 15 women) and 73 healthy controls
(48 men and 25 women) were clinically assessed with the diagnostic interview “Psychi-
atric Research Interview for Substance and Mental Disorders.” Plasma concentrations of
chemokines, cytokines, N -acyl-ethanolamines, and 2-acyl-glycerols were analyzed accord-
ing to history of cocaine addiction and sex, controlling for covariates age and body mass
index (BMI). Relationships between these concentrations and variables related to cocaine
addiction were also analyzed in addicted subjects. The results showed that the concentra-
tions of chemokine (C-C motif) ligand 2/monocyte chemotactic protein-1 (CCL2/MCP-1) and
chemokine (C-X-C motif) ligand 12/stromal cell-derived factor-1 (CXCL12/SDF-1) were only
affected by history of cocaine addiction. The plasma concentrations of interleukin 1-beta
(IL-1β), IL-6, IL-10, and tumor necrosis factor-alpha (TNFα) were affected by history of cocaine
addiction and sex. In fact, whereas cytokine concentrations were higher in control women
relative to men, these concentrations were reduced in cocaine-addicted women without
changes in addicted men. Regarding fatty acid derivatives, history of cocaine addiction had
a main effect on the concentration of each acyl derivative, whereas N -acyl-ethanolamines
were increased overall in the cocaine group, 2-acyl-glycerols were decreased. Interestingly,
N -palmitoleoyl-ethanolamine (POEA) was only increased in cocaine-addicted women. The
covariate BMI had a significant effect on POEA and N -arachidonoyl-ethanolamine con-
centrations. Regarding psychiatric comorbidity in the cocaine group, women had lower
incidence rates of comorbid substance use disorders than did men. For example, alco-
hol use disorders were found in 80% of men and 40% of women. In contrast, the
addicted women had increased prevalences of comorbid psychiatric disorders (i.e., mood,
anxiety, and psychosis disorders). Additionally, cocaine-addicted subjects showed a rela-
tionship between the concentrations of N -stearoyl-ethanolamine and 2-linoleoyl-glycerol
and diagnosis of psychiatric comorbidity.These results demonstrate the existence of a sex
influence on plasma biomarkers for cocaine addiction and on the presence of comorbid
psychopathologies for clinical purposes.
Keywords: cocaine use disorders, psychiatric comorbidity, cytokine, endocannabinoid, sex, outpatient, biomarker,
abstinence
www.frontiersin.org February 2015 | Volume 6 | Article 17 | 1
Pedraz et al. Sex and cocaine addiction
INTRODUCTION
Over the last 10 years, cocaine has established itself as the most
commonly used illicit stimulant drug in Europe, although most
users are found in a small number of high-prevalence countries.
Cocaine use is particularly high in Spain, with a lifetime prevalence
of 10.2% in the general population, and it represents a significant
public health concern (1).
There are several factors that influence the acquisition, main-
tenance, and progression to addiction, such as social context, age,
genetic characteristics, and sex (2). In this respect, sex differences
have been found in cocaine use and addiction, including cocaine
use initiation, progression to abuse and dependence, relapse
following abstinence, and responsiveness to treatment (3–5).
Epidemiological data suggest that women have a rapid escala-
tion in drug use and progress more quickly to cocaine addiction
compared with men (6). Women are more sensitive to social
stressors, and abstinent cocaine-addicted women report higher
levels of craving in response to cocaine-related cues (7, 8). Sex
also influences treatments and relapses because women report
shorter abstinence periods and higher relapse rates after stressful
or depressive events (9). All of these observations parallel preclin-
ical animal models using rodents showing that females are more
vulnerable to the abuse-related effects of cocaine than males (10).
Despite evidence that women are more vulnerable than men to
cocaine addiction, the rates of cocaine use are currently higher
in men than in women, and the proportion of cocaine users
seeking treatment in outpatient cocaine programs is approxi-
mately five men to every woman in Europe (1). Considering that
cocaine addiction is commonly associated with altered executive
functions, impaired emotional processing capacity, and elevated
incidence of comorbid mental disorders (11, 12), sex is a primary
factor underlying these behavioral complications. In fact, sex dif-
ferences in psychopathologies and substance use disorders have
been linked to the activity of hormones (i.e., gonadal steroid hor-
mones), menstrual cycle, HPA axis reactivity, and neurobiological
factors (13–15).
Recently, the search for biomarkers for psychiatric disorders
and addiction has generated a number of putative biomarkers
that includes circulating mediators with neuromodulatory func-
tions (16–18). Among these molecules, inflammatory proteins and
fatty acid derivatives have been reported to be altered in abstinent
cocaine-addicted subjects (19, 20). Moreover, changes in plasma
cytokine and chemokine concentrations have been shown to be
related to the pathological cocaine use and cocaine symptom sever-
ity (20), whereas changes in endocannabinoids and congeners are
related to cocaine use disorders and psychiatric comorbidity (19).
However, the influence of sex was not directly studied in these
reports.
Abbreviations: 2-AG, 2-arachidonoyl-glycerol; 2-LG, 2-linoleoyl-glycerol; AEA,
N-arachidonoyl-ethanolamine; CCL2/MCP-1, chemokine (C-C motif) ligand
2/monocyte chemotactic protein-1; CXCL12/SDF-1, chemokine (C-X-C motif)
ligand 12/stromal cell-derived factor-1; CX3CL1/fractalkine, chemokine (C-X3-
C motif) ligand 1/fractalkine; IL-1β, interleukin-1 beta; IL-6, interleukin-6; IL-
10, interleukin-10; LEA, N -linoleoyl-ethanolamine; OEA, N -oleoyl-ethanolamine;
PEA, N -palmitoyl-ethanolamine; POEA, N -palmitoleoyl-ethanolamine; SEA, N -
stearoyl-ethanolamine; TNFα, tumor necrosis factor-alpha.
Because previous studies have reported sex differences in all
phases related to the progression to cocaine addiction and because
gonadal hormones can affect other signaling systems sensitive to
cocaine addiction, those molecules identified as putative biomark-
ers for cocaine addiction and common psychiatric comorbidity
may be influenced by sex.
The primary purpose of the present observational study was
to examine the plasma concentrations of chemokines, cytokines,
and fatty acid derivatives in a cohort of abstinent cocaine-addicted
subjects on an outpatient basis according to their sex. Addition-
ally, the prevalences of comorbidity of other substance and mental
disorders were evaluated.
MATERIALS AND METHODS
SUBJECTS AND RECRUITMENT
All participants were white Caucasians grouped into abstinent
cocaine users and healthy controls. Fifty-nine cocaine users (17
women and 42 men) were initially enrolled from outpatient treat-
ment programs for cocaine addiction in the province of Málaga
(Spain) for a 24-month period (2011–2013). Seventy-six healthy
individuals (25 women and 51 men) were recruited from a mul-
tidisciplinary staff working at the Hospital Regional Universitario
de Málaga.
Cocaine users had to meet eligibility criteria based on inclu-
sion and exclusion criteria. Inclusion criteria were as follows:
≥18–65 years of age, intranasal cocaine use, diagnosis of life-
time cocaine use disorders, and abstinence from cocaine for at
least 2 weeks before testing (urine and plasma analyses). Exclu-
sion criteria were as follows: personal history of chronic diseases
(e.g., cardiovascular, respiratory, renal, hepatic, neurological, or
endocrine diseases), personal history of cancer, infectious diseases,
incapacitating cognitive alterations, and pregnancy.
Controls were matched with the cocaine group for sex ratio, age,
and body mass index (BMI). In addition to the mentioned exclu-
sion criteria for abstinent cocaine users, controls were excluded if
they had a personal history of drug abuse or lifetime psychiatric
disorders. All women were recruited without considering their
menstrual cycle.
Finally, 55 abstinent cocaine-addicted subjects (15 women and
40 men) and 63 controls (25 women and 48 men) met the eligibility
criteria and completed the study.
All cocaine-addicted subjects were under current treat-
ment interventions, including pharmacological and behavioral
approaches. Regarding the pharmacological interventions, 20 par-
ticipants (12 men and 8 women) were treated with anxiolyt-
ics (n= 9), antipsychotics (n= 2), antidepressants (n= 8), and
disulfiram (n= 1).
CLINICAL ASSESSMENTS
Cocaine users were evaluated according to “Diagnostic and Sta-
tistical Manual of Mental Disorders-4th Edition-Text Revision”
(DSM-IV-TR) criteria, using the Spanish version of the “Psy-
chiatric Research Interview for Substance and Mental Disorders”
(PRISM) (21, 22). Controls were evaluated by PRISM (for sub-
stance screening and abuse and dependence) and the Spanish
version of the “Composite International Diagnostic Interview”
(CIDI) to detect psychiatric disorders (23). All interviews were
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performed by experienced psychologists who had received both
PRISM and CIDI training. Two cocaine users did not meet the cri-
teria for cocaine use disorders and three controls were diagnosed
with lifetime mental disorders (major depression and anxiety).
They were consequently excluded from the study.
Psychiatric research interview for substance and mental disorders
(PRISM)
The PRISM is a semistructured interview to diagnose psychi-
atric disorders among substance users (22, 24, 25). Diagnoses
were made using two time-frames: “current” (criteria were met
within the past year) and “past” (criteria were met before the pre-
vious 12 months). Lifetime prevalence was used to present the
frequency of substance use disorders, non-substance use disorders,
and psychiatric comorbidity. The cocaine symptom severity was
assessed combining the DSM-IV-TR criteria for cocaine use dis-
orders: 7 dependence criteria (for a diagnosis of dependence, 3 or
more co-occurring symptoms in a 12-month period are required)
and 4 abuse criteria (1 symptom is necessary for a diagnosis of
abuse) (19, 20).
LABORATORY METHODS FOR HUMAN SAMPLES
Collection and analysis of plasma samples
Blood samples were obtained in the morning (09:00–11:00 a.m.)
after fasting for 8–12 h (previous to the psychiatric interviews).
Venous blood was collected into 10 mL K2-EDTA tubes (BD,
Franklin Lakes, NJ, USA) and processed to obtain plasma. Blood
samples were centrifuged at 2,200× g for 15 min (4°C), and
plasma was analyzed for HIV and hepatitis types B and C.
Analysis for HIV and hepatitis types B and C. Plasmas sam-
ples were individually assayed by three rapid tests for detecting
HIV (Retroscreen HIV, QualPro Diagnostics-Tulip Group Ltd.,
Goa, India), hepatitis B (HBsAg Test, Toyo Diagnostics-Turklab
Inc., Izmir, Turkey), and hepatitis C (Flaviscreen HCV, QualPro
Diagnostics-Tulip Group Ltd., Goa, India). No samples that tested
positive were detected. Plasma samples were stored at−80°C until
further analyses.
Analysis for the cocaine metabolite benzoylecgonine. Plasma
analyses for cocaine metabolites (Benzoylecgonine Specific Direct
ELISA Kit Immunalysis, Pomona, CA, USA) were performed to
confirm cocaine abstinence. Two cocaine users who tested nega-
tive for drugs of abuse in urine analyses at the outpatient treatment
centers for cocaine addiction were positive for benzoylecgonine in
plasma, and they were excluded from this study.
Multiplex immunoassay analysis
A Bio-Plex Suspension Array System 200 (Bio-Rad Laboratories,
Hercules, CA, USA) was used to quantify the plasma concentra-
tions of inflammatory cytokines and chemokines following the
manufacturer’s instructions as previously reported (20). Human
protein panels were used to simultaneously detect the following
analytes: tumor necrosis factor-alpha (TNFα); interleukin-1 beta
(IL-1β); interleukin-6 (IL-6); interleukin-10 (IL-10); chemokine
(C-X3-C motif) ligand 1 [CX3CL1], commonly referred to as
fractalkine; chemokine (C-C motif) ligand 2 [CCL2], also referred
to as monocyte chemotactic protein-1 (MCP-1); and chemokine
(C-X-C motif) ligand 12 [CXCL12], also referred to stromal cell-
derived factor-1 (SDF-1). Raw data (mean fluorescence intensity)
were analyzed using the Bio-Plex Manager Software 4.1 (Bio-Rad
Laboratories, Hercules, CA, USA). Data of plasma concentrations
were in pg of protein per mL of plasma.
Quantification of fatty acid derivatives
The following fatty acid derivatives and their respective deuter-
ated forms were used for quantification:N -stearoyl-ethanolamine
(SEA), N -palmitoyl-ethanolamine (PEA) and PEA-d4, N -oleoyl-
ethanolamine (OEA) and OEA-d4,N -palmitoleoyl-ethanolamine
(POEA), N-arachidonoyl-ethanolamine (AEA) and AEA-d4,
N -linoleoyl-ethanolamine (LEA) and LEA-d4, 2-arachidonoyl-
glycerol (2-AG) and 2-AG-d5, and 2-linoleoyl-glycerol (2-LG).
PEA-d4 and OEA-d4 were used for the quantification of POEA
and SEA, respectively, because their deuterated forms were not
commercially available. All reagents were obtained from Cayman
Chemical (Ann Arbor, MI, USA).
Sample extraction and chromatographic separation were per-
formed in a liquid chromatography-tandem mass spectrometry
system (Agilent Technologies, Wilmington, DE, USA) as previ-
ously reported (19, 26). Data of plasma concentrations were in ng
of acyl derivative per mL of plasma.
ETHICS STATEMENT
Written informed consent was obtained from each subject after
they had received a complete description of the present study
and had been given the chance to discuss any questions or
issues. The study and protocols for recruitment were approved
by the Ethics Committee of the Hospital Regional Universitario de
Málaga (07/19/2009 PND049/2009 and PI0228-2013; CEI Provin-
cial de Málaga) and were therefore conducted in accordance with
the Declaration of Helsinki (seventh revision in 2013, Fortaleza,
Brazil).
STATISTICAL ANALYSES
All data for graphs and tables are expressed as number and per-
centage of subjects [n (%)] or the mean and standard deviation
[mean (SD)]. Samples were grouped by sex and the signifi-
cance of differences was assessed by Fisher’s exact test or Stu-
dent’s t -test. The statistical analyses of plasma concentrations
were performed using two-way analysis of covariance (ANCOVA)
[factors: history of cocaine addiction (cocaine/control) and sex
(men/women); covariates: age and BMI]. Multiple comparisons
were performed with unadjusted (observed) or adjusted (esti-
mated marginal) according to the effects of covariates. Plasma
concentrations in subjects with a history of cocaine addiction
were analyzed by univariate general linear models to evalu-
ate relationships with sex, age, BMI, and group-specific vari-
ables (cocaine symptom severity, diagnosis of comorbid psy-
chiatric disorders, and length of cocaine abstinence). A p-value
less than 0.05 was considered statistically significant. Statisti-
cal analyses were performed using the GraphPad Prism ver-
sion 5.04 software (GraphPad Software, San Diego, CA, USA)
and IBM SPSS Statistical version 22 software (IBM, Armonk,
NY, USA).
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RESULTS
SOCIAL AND DEMOGRAPHIC CHARACTERISTICS
A total of 128 subjects met the eligibility criteria for this study
and were grouped into the cocaine (n= 55) and control (n= 73)
groups. Both groups were divided into men and women. A
description of the sample is presented in Table 1.
Men seeking treatment for cocaine addiction were more com-
mon than women, at a ratio of one woman to eight men in the
centers for cocaine addiction where the recruitment was con-
ducted (data not shown). During a 24-month period (January
2011–December 2012), 20 women were contacted to participate in
this study; 17 accepted and were diagnosed with lifetime cocaine
use disorders. Finally, 15 cocaine-addicted women completed the
study. Whereas the abstinent cocaine-addicted men had a mean
age of 37 years, the cocaine-addicted women were older (mean:
43 years; p< 0.01). We observed no differences between the sexes
in other socio-demographic variables in the cocaine group. Con-
sidering both sexes, the addicted subjects were married/cohabiting
(47%), lived in couple (49%), had a low educational level (42%
with secondary level or more), and were unemployed (58%). In
contrast, the control subjects had a higher educational level (96%
with secondary level or more) and employment rate (89%).
Interestingly, the cocaine-addicted subjects displayed a higher
incidence in the use of psychological counseling, excluding treat-
ments of severe/serious mental disorders, with 30% in men and
60% in women. These percentages were reduced in the control
group to 8% in men and 48% in women.
COMORBID MENTAL AND SUBSTANCE USE DISORDERS IN ABSTINENT
COCAINE-ADDICTED SUBJECTS GROUPED BY SEX
Comorbid substance use disorders and cocaine use-related
variables
As shown in Table 2, the cocaine group had an elevated preva-
lence of comorbid substance use disorders in addition to cocaine
use disorders, primarily alcohol (69%) and cannabis (20%) use
disorders. We observed sex differences in the prevalences of
these other substance use disorders because they were more
common in men than in women: alcohol use disorders were
diagnosed in 80% of men and 40% of women (p< 0.01), and
cannabis use disorders were diagnosed in 25% of men and 7% of
women.
Focusing on the variables related to cocaine use, we did not
observe sex differences in the prevalences of abuse and depen-
dence, length of cocaine abstinence, duration of cocaine use, or
cocaine symptom severity. Therefore, the average cocaine-addicted
subject, including men and women, displayed cocaine abstinence
for 178.6 (281.7) days [mode: 120 days (range: 730)], a cumulative
cocaine use of 8.2 (6.6) years [mode: 4 years (range: 31)] and 8.1
(2.5) DSM-IV criteria for cocaine use disorders.
Comorbid mental disorders
Regarding the common psychiatric disorders assessed with the
PRISM, we found high prevalences of comorbid psychopatholo-
gies (60%): mood (38%), anxiety (22%), psychosis (20%), and
personality (35%) disorders.
Table 1 | Baseline socio-demographic variables in abstinent cocaine-addicted and control subjects grouped by sex.
Variable Cocaine group Control group
Men Women Men Women
Sex [n (%)] 40 (72.7) 15 (27.3) 48 (65.8) 25 (34.2)
Age (≥18) [Mean (SD)] 37.1 (6.7) 42.8 (6.2)* 38.6 (9.8) 42.6 (8.4)
Body mass [Mean (SD)] Body mass index 26.2 (4.3) 25.4 (5.9) 25.4 (5.9) 23.9 (4.7)
Current marital status [n (%)] Never married 12 (30.0) 4 (26.7) 23 (47.9) 10 (40.0)
Married/cohabiting 19 (47.5) 7 (46.7) 22 (45.8) 10 (40.0)
Divorced/separated 9 (22.5) 3 (20.0.) 3 (6.3) 4 (16.0)
Widowed 0 (0.0) 1 (6.7) 0 (0.0) 1 (4.0)
Living together last year [n (%)] Friends, squatters 1 (2.5) 1 (6.7) 3 (6.3) 0 (0.0)
Parents 14 (35.0) 5 (33.3) 9 (18.8) 7 (28.0)
Couple 20 (50.0) 7 (46.7) 25 (52.1) 12 (48.0)
Alone 4 (10.0) 1 (6.7) 10 (20.8) 6 (24.0)
Others 1 (2.5) 1 (6.7) 1 (2.1) 0 (0.0)
Educational level [n (%)] ≤ Primary level 24 (60.0) 8 (53.3) 3 (6.3) 0 (0.0)
≥ Secondary level 16 (40.0) 7 (46.7) 45 (93.8) 25 (100.0)
Work status [n (%)] Employed 16 (40.0) 4 (26.7) 42 (87.5) 23 (92.0)
Unemployed 22 (55.0) 10 (66) 5 (10.4) 2 (8.0)
Retired/disabled 2 (5.0) 1 (6.7) 0 (0.0) 0 (0.0)
Student 0 (0.0) 0 (0.0) 1 (2.1) 0 (0.0)
Use of psychological resources [n (%)] No 28 (70.0) 6 (40.0) 44 (91.7) 13 (52.0)
Yes 12 (30.0) 9 (60.0) 4 (8.3) 12 (48.0)
*p<0.05 denotes significant differences between cocaine-addicted men and women.
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Table 2 | Cocaine use-related variables in abstinent cocaine-addicted subjects grouped by sex.
Variable Cocaine group p-Value
Men (n=40) Women (n=15)
Lifetime substance use disorders [n (%)] Cocaine use disorders 40 (100.0) 15 (100.0) ns
Alcohol use disorders 32 (80.0) 6 (40.0) 0.008
Cannabis use disorders 10 (25.0) 1 (6.7) ns
Other substance use disorders 9 (22.5) 2 (13.3) ns
Lifetime cocaine use disorders [n (%)] Cocaine abuse 35 (87.5) 14 (93.3) ns
Cocaine dependence 36 (90.0) 13 (86.7) ns
Cocaine abuse and dependence 31 (77.5) 12 (80.0) ns
Cocaine abstinence [Mean (SD)] Days 184.2 (323.2) 163.7 (145.2) ns
Cocaine use [Mean (SD)] Years 8.0 (6.8) 9.6 (6.5) ns
DSM-IV criteria for cocaine use disorders [Mean (SD)] Counts 8.1 (2.5) 7.9 (1.9) ns
ns, non-significant.
Bold indicates statistically significant p-values.
Table 3 | Psychiatric comorbidity in abstinent cocaine-addicted subjects grouped by sex.
Variable Cocaine group p-value
Men (n=40) Women (n=15)
Lifetime psychiatric disordersa [n (%)] No 18 (45.0) 4 (26.7) ns
Mood disorders 13 (32.5) 8 (53.3) ns
Anxiety disorders 5 (12.5) 7 (46.7) 0.011
Psychosis disorders 6 (15.0) 5 (33.3) ns
Eating disorders 0 (0.0) 0 (0.0) –
Personality disorders 14 (35.0) 5 (33.3) ns
Mood disorders [n (%)] Primary 6 (15.0) 2 (13.3) ns
Cocaine-induced 7 (17.5) 5 (33.3)
Primary and cocaine-induced 0 (0.0) 1 (6.7)
Anxiety disorders [n (%)] Primary 2 (5.0) 3 (20.0) ns
Cocaine-induced 3 (7.5) 2 (13.3)
Primary and cocaine-induced 0 (0.0) 2 (6.7)
Psychosis disorders [n (%)] Primary 0 (0.0) 0 (0.0) ns
Cocaine-induced 6 (15.0) 5 (33.3)
Primary and cocaine-induced 0 (0.0) 0 (0.0)
Personality disorders [n (%)] Borderline 6 (15.0) 3 (20.0) ns
Antisocial 6 (15.0) 1 (6.7)
Borderline and antisocial 2 (5.0) 1 (6.7)
aPsychiatric disorders diagnosed with PRISM.
ns, non-significant.
Bold indicates statistically significant p-values.
According to sex, cocaine-addicted women showed higher
prevalences of mood, anxiety (p< 0.05), and psychosis disorders
compared with cocaine-addicted men (Table 3). Though some
women were diagnosed with both primary and cocaine-induced
disorders for mood and anxiety disorders, no men were diagnosed
with primary and cocaine-induced disorders (the two together).
However, these psychiatric prevalences were not significantly
different between men and women, although there was a limitation
in the sample size considered.
Regarding personality disorders, we observed no differences
between the sexes.
PLASMA CONCENTRATIONS OF CHEMOKINES ACCORDING TO
HISTORY OF COCAINE ADDICTION AND SEX
The mean plasma concentrations of CX3CL1/fractalkine, CCL2/
MCP-1, and CXCL12/SDF-1 in the cocaine and control groups are
shown in Figure 1. Two-way ANCOVAs were performed to ana-
lyze the chemokine concentrations. Covariates age and BMI were
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FIGURE 1 | Plasma concentrations of chemokines in abstinent
cocaine-addicted and control subjects grouped by sex. (A) CX3CL1/
fractalkine (pg/mL); (B) CCL2/MCP-1 (pg/mL); and (C) CXCL12/SDF-1
(pg/mL). The bars represent means±SD. The data were analyzed by
two-way ANCOVA and multiple comparison tests. (**) p< 0.01 and (***)
p<0.001 denote significant differences compared with the respective
control men or control women.
included in the analyses but there was not a significant effect of
the covariates on either chemokine concentrations.
We did not observe main effects of history of cocaine addiction
and sex on plasma CX3CL1 concentrations, but there was a sig-
nificant interaction effect (F1,122= 4.60, p= 0.034) (Figure 1A).
However, the plasma concentrations of CCL2 were significantly
affected by history of cocaine addiction (F1,122= 42.03,p< 0.001)
(Figure 1B). The multiple comparisons showed that cocaine-
addicted men and women had significantly decreased CCL2
concentrations (***p< 0.001) compared with their respective
controls. Similarly, history of cocaine addiction (F1,122= 7.72,
p= 0.006) had a significant main effect on CXCL12 concentrations
(Figure 1C). In this case, we detected a significant decrease
in cocaine-addicted women (**p< 0.01) compared with control
women, but this difference was not found in men.
Therefore, sex had no significant primary effect on chemokine
concentrations.
PLASMA CONCENTRATIONS OF CYTOKINES ACCORDING TO HISTORY
OF COCAINE ADDICTION AND SEX
The plasma concentrations of IL-1β, IL-6, IL-10, and TNFα in
the cocaine and control groups are illustrated in Figure 2. Again,
there was not a significant relationship between the covariates and
cytokine concentrations.
As shown in Figure 2A, the IL-1β concentrations were sig-
nificantly affected by history of cocaine addiction (F1,122= 5.73,
p= 0.018) and by sex (F1,122= 20.41, p< 0.001). An interaction
between history of cocaine addiction and sex was also detected
(F1,122= 8.36, p= 0.005). The paired comparisons revealed that
control women had significantly increased IL-1β concentrations
(+ + + p< 0.001) compared with control men (3.81± 2.06
and 1.40± 1.55 pg/mL, respectively). However, cocaine-addicted
women had a significant decrease in the IL-1β concentrations
(**p< 0.01) relative to control women but exhibited no differ-
ences compared with cocaine-addicted men.
The IL-6 concentrations (Figure 2B) were also significantly
affected by history of cocaine addiction (F1,122= 13.46,p< 0.001)
and sex (F1,122= 11.05,p= 0.001). Additionally, there was a signif-
icant interaction between the factors (F1,122= 13.35, p< 0.001).
Thus, although control women had higher IL-6 concentra-
tions (+ + + p< 0.001) than did control men (5.98± 2.41
and 3.37± 2.08 pg/mL, respectively), the IL-6 concentrations in
cocaine-addicted women were significantly lower (***p< 0.001)
than in control women.
In relation to IL-10 (Figure 2C), history of cocaine addic-
tion (F1,122= 8.69, p= 0.004) and sex (F1,122= 11.14, p= 0.001)
had a significant primary effect on the IL-10 concentrations.
There was an interaction between the factors (F1,122= 25.63,
p< 0.001). Considering the post hoc comparisons, control women
had increased IL-10 concentrations (+ + p< 0.01) relative to
control men (2.20± 1.12 and 1.32± 1.06 pg/mL, respectively). In
addition, cocaine-addicted women exhibited a significant decrease
in IL-1β concentrations (*p< 0.05) compared with control
women, but cocaine-addicted women had higher concentrations
(+ p< 0.05) than did cocaine-addicted men.
Finally, the statistical analysis of TNFα concentrations
(Figure 2D) revealed a significant main effect of history of cocaine
addiction (F1,122= 34.98, p< 0.001) and sex (F1,122= 20.90,
p< 0.001) after adjusting for covariates. There was an interac-
tion between history of cocaine addiction and sex (F1,122= 22.46,
p< 0.001). Once again, control women had higher TNFα
concentrations (+ + + p< 0.001) than did control men
(32.55± 16.21 and 13.47± 11.28 pg/mL, respectively). Cocaine-
addicted women showed a significant decrease in TNFα concen-
trations (***p< 0.001) compared with control women, but no
differences compared with cocaine-addicted men.
Therefore, we observed higher cytokine concentrations in
women than in men. Moreover, a specific and dramatic decrease in
cytokine concentrations was observed in cocaine-addicted women
but not in cocaine-addicted men.
Frontiers in Psychiatry | Addictive Disorders and Behavioral Dyscontrol February 2015 | Volume 6 | Article 17 | 6
Pedraz et al. Sex and cocaine addiction
FIGURE 2 | Plasma concentrations of cytokines in abstinent
cocaine-addicted and control subjects grouped by sex. (A) IL-1β (pg/mL);
(B) IL-6 (pg/mL); (C) IL-10 (pg/mL); and (D)TNFα (pg/mL). The bars represent
means±SD. The data were analyzed by two-way ANCOVA and multiple
comparison tests. (*) p<0.05, (**) p< 0.01, and (***) p<0.001 denote
significant differences compared with control women. (+) p<0.05, (++)
p<0.01, and (+ + +) p<0.001 denote significant differences compared with
the respective control men or cocaine-addicted men.
PLASMA CONCENTRATIONS OF FATTY ACID DERIVATIVES ACCORDING
TO HISTORY OF COCAINE ADDICTION AND SEX
The plasma concentrations of fatty acid derivatives were grouped
into the following categories: (i) saturated (SEA and PEA),
monounsaturated (POEA and OEA), and polyunsaturated (AEA
and LEA) N -acyl-ethanolamines (Figure 3) and (ii) 2-acyl-
glycerols (2-AG and 2-LG) (Figure 4). Significant relationships
between the covariates (age and BMI) and these fatty acid
derivative concentrations were detected by the statistical analysis.
N-acyl-ethanolamines
History of cocaine addiction (F1,122= 11.09, p= 0.001) had a sig-
nificant main effect on plasma SEA concentrations, but sex had
no effect (Figure 3A). There was not a significant effect of the
covariates on SEA concentrations, and the post hoc tests using
unadjusted means only indicated a significant decrease in the
cocaine-addicted men (***p< 0.001) compared with the control
men. Regarding the other saturated lipid derivative (Figure 3B),
plasma PEA concentrations were also significantly affected by his-
tory of cocaine addiction (F1,122= 11.04,p= 0.001) without effect
of the covariates. However, cocaine-addicted subjects showed sig-
nificantly higher plasma PEA concentrations than did controls in
both men (*p< 0.01) and women (**p< 0.01).
A two-way ANCOVA revealed a significant primary effect
of history of cocaine addiction (F1,122= 13.79, p< 0.001) and
sex (F1,122= 16.07, p< 0.001) on plasma POEA concentrations
(Figure 3C). Additionally, there was a significant interaction
between history of cocaine addiction and sex (F1,122= 8.45,
p= 0.004). In this case, there was a significant relationship between
BMI and POEA concentrations (F1,122= 5.11, p= 0.026), and
BMI explained 4.7% of the variance. Consequently, all pairwise
comparisons were performed using estimated marginal means
with fixed values of covariates (age= 39.41 and BMI= 25.34). The
confidence interval (CI) adjustments for the Bonferroni test indi-
cated the following estimated marginal means of POEA concentra-
tions and standard errors: 0.084± 0.008 ng/mL (0.068–0.100, 95%
CI) in control men, 0.097± 0.010 ng/mL (0.077–0.11, 95% CI)
in control women, 0.093± 0.009 ng/mL (0.076–0.110, 95% CI)
in cocaine-addicted men and 0.170± 0.015 ng/mL (0.139–0.200,
95% CI) in cocaine-addicted women. Multiple comparisons with
adjusted means indicated that the main effect of history of cocaine
addiction was exclusively observed in cocaine-addicted women. A
marked increase in plasma POEA concentrations was observed
in cocaine-addicted women (***p< 0.001) relative to control
women but also in comparison with cocaine-addicted men (+
+ + p< 0.001). There were no changes in POEA concentrations
in men.
Regarding the other monounsaturated lipid derivative
(Figure 3D), plasma OEA concentrations were only affected by
cocaine use (F1,122= 30.73, p< 0.001). There was a significant
relationship between age and OEA concentrations (F1,122= 6.84,
p= 0.010), and the covariate explained 6.2% of the vari-
ance. The adjusted means (age= 39.41 and BMI= 25.34) of
OEA concentrations and standard errors of the means were
as follows: 2.263± 0.137 ng/mL (1.991–2.536, 95% CI) in con-
trol men, 2.120± 0.175 ng/mL (1.774–2.466, 95% CI) in control
women, 3.258± 0.147 ng/mL (2.966–3.550, 95% CI) in cocaine-
addicted men and 3.180± 0.259 ng/mL (2.666–3.693, 95% CI) in
cocaine-addicted women. Multiple comparisons of these adjusted
means indicated that the cocaine group had significantly higher
plasma OEA concentrations than did the controls in both men
(**p< 0.01) and women (***p< 0.001).
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FIGURE 3 | Plasma concentrations of N -acyl-ethanolamines in abstinent
cocaine-addicted and control subjects grouped by sex. (A) SEA (ng/mL);
(B) PEA (ng/mL); (C) POEA (ng/mL); (D) OEA (ng/mL); (E) AEA (ng/mL); and
(F) LEA (ng/mL). The bars represent means±SD. The data were analyzed by
two-way ANCOVA and multiple comparison tests. (*) p<0.05, (**) p<0.01,
and (***) p<0.001 denote significant differences compared with the
respective control men or control women. (+++) p<0.001 denotes
significant differences compared with cocaine-addicted men. POEA, OEA,
and AEA concentrations are adjusted means with the following values of
covariates: age=39.41 years and BMI=25.34.
Two polyunsaturated N -acyl-ethanolamines, AEA and LEA,
were also measured and statistically analyzed. Similar to OEA
and the saturated lipid mediators, history of cocaine addic-
tion produced a main effect on plasma AEA concentrations
(F1,122= 38.59, p< 0.001) (Figure 3E). However, there was a sig-
nificant effect of BMI (F1,122= 6.29, p= 0.014) that explained
5.8% of the variance. The estimated marginal means (age= 39.41
and BMI= 25.34) of AEA concentrations were as follows:
0.467± 0.032 ng/mL (0.404–0.530, 95% CI) in control men,
0.421± 0.040 ng/mL (0.341–0.501, 95% CI) in control women,
0.668± 0.034 ng/mL (0.601–0.736, 95% CI) in cocaine-addicted
men and 0.753± 0.060 ng/mL (0.634–0.872, 95% CI) in cocaine-
addicted women. The paired comparisons showed that both
cocaine-addicted men and women had a significant increase in
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AEA concentrations (**p< 0.01 and ***p< 0.001, respectively)
compared with their respective controls.
When LEA concentrations were analyzed (Figure 3F), we
observed a significant primary effect of history of cocaine addic-
tion (F1,122= 45.80, p< 0.001). Here, an interaction between
both factors was also detected (F1,122= 5.58, p= 0.020). BMI and
age had no effect on LEA concentrations. Multiple comparisons
showed significant increases in the plasma LEA concentrations of
cocaine-addicted men (***p< 0.001) and women (***p< 0.001)
in comparison with their respective controls, but we observed no
differences between both sexes.
Overall, free N -acyl-ethanolamine concentrations were found
to be increased in the plasma of cocaine-addicted subjects with no
effect of sex. However, there were two exceptions: (i) SEA concen-
trations were decreased in the cocaine group and (ii) POEA con-
centrations were increased exclusively in cocaine-addicted women.
The covariates age and BMI were found to be significantly related
to the plasma concentrations of certain acyl derivatives (i.e., POEA,
OEA, and AEA).
2-acyl-glycerols
As shown in Figure 4, the plasma concentrations of 2-AG and
2-LG were determined to be glycerol-derived molecules.
Statistical analysis revealed a significant main effect of his-
tory of cocaine addiction (F1,122= 7.60, p= 0.007) on 2-AG
concentrations (Figure 4A). There was a significant relationship
between age and 2-AG concentrations (F1,122= 9.85, p= 0.002),
and the covariate explained 8.7% of the variance. The adjusted
means (age= 39.41 and BMI= 25.34) of 2-AG concentrations
and standard errors were as follows: 6.869± 0.508 ng/mL (5.861–
7.877, 95% CI) in control men, 5.779± 0.646 ng/mL (4.497–
7.060, 95% CI) in control women, 5.116± 0.545 ng/mL (4.035–
6.197, 95% CI) in cocaine-addicted men, and 3.749± 0.958 ng/mL
(1.849–5.650, 95% CI) in cocaine-addicted women. Paired
comparisons did not indicate significant differences among
groups.
Finally, we also found a significant primary effect of history
of cocaine addiction (F1,122= 16.57, p< 0.001) on plasma 2-LG
concentrations. We observed no effects of age or BMI on the 2-LG
concentrations. The post hoc tests indicated significant decreases
in the 2-LG concentrations of cocaine-addicted subjects compared
with the control group for both men (***p< 0.001) and women
(*p< 0.05).
Unlike N -acyl-ethanolamines, the plasma concentrations of
glycerol derivatives were decreased in the cocaine group, but
sex differences were not found. Interestingly, there was a robust
relationship between BMI and 2-AG concentrations.
PLASMA CONCENTRATIONS OF CHEMOKINES, CYTOKINES, AND FATTY
ACID DERIVATIVES IN SUBJECTS WITH A HISTORY OF COCAINE
ADDICTION
The plasma concentrations of chemokines, cytokines, and fatty
acid derivatives in the cocaine group were analyzed by univariate
general linear models to evaluate their relationships with cocaine
symptom severity, diagnosis of comorbid psychiatric disorders,
and length of cocaine abstinence (Table 4). Additionally, the
relationships with BMI, age, and sex were also evaluated.
FIGURE 4 | Plasma concentrations of 2-acyl-glycerols in abstinent
cocaine-addicted and control subjects grouped by sex. (A) 2-AG
(ng/mL); and (B) 2-LG (ng/mL). The bars represent means±SD. The data
were analyzed by two-way ANCOVA and multiple comparison tests. (*)
p<0.05 and (***) p<0.001 denote significant differences compared with
the respective control men or control women. 2-AG concentrations are
adjusted means with the following values of covariates: age=39.41 years
and BMI=25.34.
We observed no relationships between plasma concentrations
of chemokines and cytokines and such variables. In fact, the main
effect of sex on cytokine concentrations in the control and cocaine
groups was not observed when only the cocaine group was ana-
lyzed. However, the plasma concentrations of several fatty acid
derivatives were found to be associated with certain variables.
Thus, SEA concentrations were related to the diagnosis of
comorbid psychopathologies (p< 0.01), and an increase in SEA
concentrations was observed in cocaine-addicted subjects diag-
nosed with psychiatric comorbidity. As previously observed,
POEA and AEA concentrations in the cocaine group were found
to be affected by BMI (p< 0.05). Additionally, there was a main
effect of sex (p= 0.001) on POEA concentrations. Regarding
2-acyl glycerol derivatives, whereas 2-AG concentrations were
significantly affected by age and sex (p< 0.05), 2-LG concentra-
tions were affected by diagnosis of psychiatric comorbidity and
sex (p< 0.05). Similar to SEA, an increase in 2-LG concentra-
tions was observed in cocaine subjects diagnosed with psychiatric
comorbidity.
Thus, among the independent variables related to cocaine
addiction in the cocaine group that were evaluated, we only found
significant associations between comorbid psychiatric disorders
and fatty acid derivative concentrations (i.e., SEA and 2-LG).
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Table 4 | Multiple relationships between plasma concentrations of chemokines, cytokines, and fatty acid derivatives (dependent variables) and
independent variables in abstinent cocaine-addicted subjects.
Dependent variable Main effect (independent variable)a
Sex Body
mass
index
Age Length of
cocaine
abstinence
Cocaine
symptom
severity
Comorbid
psychiatric
disorders
F p-value F p-value F p-value F p-value F p-value F p-value
UNIVARIATE GENERAL LINEAR MODELS
CX3CL1 (fractalkine) 2.194 ns 0.930 ns 0.222 ns 0.010 ns 2.469 ns 0.354 ns
CCL2 (MCP-1) 0.005 ns 0.949 ns 0.657 ns 0.524 ns 0.687 ns 3.204 ns
CXCL12 (SDF-1) 0.452 ns 0.018 ns 0.026 ns 0.001 ns 2.651 ns 0.011 ns
IL-1β 1.162 ns 0.433 ns 0.545 ns 0.121 ns 2.550 ns 2.434 ns
IL-6 0.012 ns 0.272 ns 0.854 ns 0.411 ns 1.872 ns 3.690 ns
IL-10 2.103 ns 1.091 ns 2.407 ns 1.791 ns 1.033 ns 2.765 ns
TNFα 0.165 ns 0.004 ns 0.036 ns 0.076 ns 0.218 ns 3.032 ns
SEA 0.004 ns 0.774 ns 0.266 ns 1.408 ns 1.842 ns 11.49 0.002
PEA 1.246 ns 0.911 ns 1.116 ns 0.490 ns 1.746 ns 1.858 ns
OEA 0.300 ns 0.095 ns 1.181 ns 0.098 ns 0.501 ns 2.177 ns
POEA 12.88 0.001 6.798 0.013 0.011 ns 0.427 ns 0.185 ns 0.037 ns
AEA 0.453 ns 4.578 0.039 0.166 ns 0.265 ns 2.842 ns 2.691 ns
LEA 2.601 ns 3.458 ns 0.144 ns 0.138 ns 1.584 ns 0.946 ns
2-AG 4.593 0.039 0.149 ns 6.619 0.014 0.503 ns 0.004 ns 2.288 ns
2-LG 6.703 0.014 0.063 ns 2.981 ns 0.003 ns 0.692 ns 6.897 0.012
aTests of between-subjects effects.
ns, non-significant.
Bold indicates statistically significant p-values.
DISCUSSION
The present findings show that sex is a relevant modulatory factor
in the presence of comorbid mental and substance use disorders
in individuals with lifetime cocaine use disorders. As expected,
cocaine-addicted men seeking treatment were more common than
women. Whereas the abstinent cocaine-addicted men were char-
acterized by increased rates of other substance use disorders such
as alcohol and marijuana, the cocaine-addicted women showed a
higher prevalence of comorbid mental disorders, such as mood,
anxiety, and psychotic disorders. Additionally, the plasma concen-
trations of putative biomarkers for cocaine addiction and comor-
bidity were influenced by sex. In the present study,we examined sex
differences in inflammatory mediators and fatty acid derivatives
because these molecules were reported to be affected by the patho-
logical use of cocaine (19, 20). The most relevant findings were that
all of the evaluated inflammatory cytokines and the monounsat-
urated fatty acid derivative POEA were found to be differentially
altered in cocaine-addicted women, extending the influence of sex
to plasma biomarkers for cocaine addiction. In addition, SEA and
2-LG concentrations were associated with psychiatric comorbidity
in abstinent cocaine-addicted subjects.
In the present study, subjects diagnosed with lifetime cocaine
use disorders showed high rates of mental and other substance
use disorders, as reported previously in cocaine users and absti-
nent cocaine-addicted subjects (11, 12, 27), and there were dif-
ferences in the psychiatric prevalence according to sex. Several
epidemiological studies have observed significant sex differences
among subjects diagnosed with mood and anxiety disorders.
The incidence of mental disorders is enhanced in women com-
pared with men, particularly in periods of life such as preg-
nancy, maternity, menopause, or after traumatic events (15).
These elevated rates of lifetime psychiatric disorders in women
have also been reported with substance use disorders (14, 28).
Consistent with these previous studies, we diagnosed a higher
prevalence of comorbid mental disorders (i.e., mood, anxiety,
and psychosis) in women, whereas higher rates of other sub-
stance use disorders (especially with alcohol) were observed in
cocaine-addicted men. As expected, the lifetime cocaine symp-
tom severity was severe in both sexes with no differences with
respect to length of abstinence and duration of cumulative
cocaine use.
Collectively, these findings suggest that any potential bio-
marker for cocaine addiction and psychiatric comorbidity must
account for the influence of sex. Recent evidence indicates that
cocaine and other psychostimulants alter the peripheral concen-
tration of circulating mediators that may influence the cognitive
and behavioral changes associated with the process of addiction.
Among these mediators, we assessed the plasma concentrations of
inflammatory mediators and fatty acid derivatives. Chemokines
and proinflammatory mediators are affected by cocaine symp-
tom severity, whereas anti-inflammatory fatty acid derivatives
such as endocannabinoids and their congeners are affected by
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the history of pathological use of cocaine and the presence of
comorbid disorders. However, the impact of sex has not been suf-
ficiently studied because the female population seeking outpatient
treatment in centers for cocaine addiction is very low, as previously
indicated (1).
CHEMOKINE AND CYTOKINE CONCENTRATIONS
Growing evidence has demonstrated naturally occurring sex dif-
ferences in the immune response and inflammatory mediators.
During their reproductive years, women have a more potenti-
ated cellular and humoral immune response than do men (29).
Indeed, it is thought that fluctuations in estrogen may alter
immune cell function by affecting cytokine and chemokine pro-
duction (30). Furthermore, several recent reports have related
inflammatory mediators in blood and cerebrospinal fluid to addic-
tion to drugs of abuse, such as alcohol, psychostimulants, and
opiates (31).
Chemokines are chemoattractants that are involved in leuko-
cyte trafficking to the site of inflammation (32), but they also
play an important role in neuronal development, maturation,
survival, and regeneration in the central nervous system (CNS)
(33). Therefore, cerebral changes underlying addiction and psy-
chiatric comorbidities might be reflected in peripheral alterations.
Recently, chemokines have been proposed as pathologically rel-
evant biomarkers or therapeutic targets for psychiatric disorders
(34). In fact, we found that the CCL2 and CXCL12 concentra-
tions were decreased in both male and female cocaine users. These
changes in circulating chemokines are in accordance with the
results from another study in abstinent cocaine-addicted popu-
lation, which suggested that these chemokines were biomarkers
for the pathological use of cocaine, although we observed no
changes in plasma CX3CL12 concentrations (20). Moreover, we
detected no differences by sex in the plasma concentrations of
these chemokines.
In addition to chemokines, we evaluated plasma cytokine con-
centrations, including pro- and anti-inflammatory mediators. In
this case, we found a clear sexual dimorphism in the circulating
concentrations of all of the cytokines assessed in the present study.
The plasma concentrations of IL-1β, IL-6, IL-10, and TNFα were
higher in healthy women compared with men. Interestingly, these
differences were absent in subjects diagnosed with lifetime cocaine
use disorders.
Previous studies have reported that chronic exposure to drugs
of abuse, such as alcohol and cocaine, suppresses immune
responses. Contradictory data have been published in relation
to alcoholism. For instance, whereas a significant increase in the
production of IL-1β, IL-6, IL-12, and TNFα was observed in
chronic alcoholics without liver disease, chronic alcoholics with
liver disease who were drinking alcohol showed low produc-
tion of IL-1β and TNFα (35). Regarding cocaine, it has been
reported that cocaine-dependent subjects show a decreased capac-
ity to express proinflammatory cytokines such as TNFα and IL-6
in monocytes (36). Further, we have recently shown that absti-
nent cocaine-addicted subjects have low TNFα concentrations and
IL-1β concentrations, and that they are affected by the cocaine
symptom severity (20). Our data may be related to long-term
cocaine-induced changes in cytokine concentrations, but these
changes were only produced in women with no effect in male
addicts. The plasma concentrations of inflammatory cytokines
were clearly reduced in women, and such cytokine reduction might
be associated with decreased immune activity and an increased
risk of developing mental disorders (15, 37). However, plasma
concentrations of chemokines and cytokines were not associated
with sex and comorbid psychopathologies in cocaine-addicted
subjects.
FATTY ACID DERIVATIVE CONCENTRATIONS
Several lines of evidence suggest that bioactive lipids, such as endo-
cannabinoids and related congeners, are involved in the acquisition
and maintenance of drug-taking behavior and other processes
associated with addiction (38, 39). However, all of these stud-
ies are based on preclinical observations because there are few
studies concerning plasma lipid derivatives in individuals with
substance use disorders (40, 41), principally with alcohol use (42,
43). Endocannabinoids act on cannabinoid receptors to exert their
effects and are composed of two structural types of lipid deriv-
atives: N -acyl-ethanolamines (e.g., AEA) and 2-acyl-glycerols
(e.g., 2-AG).
Clinical studies in alcohol users reported that alcohol use affects
circulating endocannabinoid concentrations after moderate and
chronic consumption (42, 43). Regarding cocaine use, we recently
showed that N -acyl-ethanolamine concentrations are increased
in abstinent cocaine addicts, whereas both 2-AG and 2-LG are
reduced (19). Interestingly, distinct profiles of both endocannabi-
noid types (AEA and 2-AG) have also been described in distinct
brain areas after administering drugs of abuse in rodents (44,
45). In agreement with these studies, the present study shows
that plasma concentrations of all lipid-derived molecules were
distinctly affected by history of cocaine addiction. All N -acyl-
ethanolamines, except SEA, were found to be increased in cocaine-
addicted subjects, but 2-acyl-glycerols were decreased in relation
to healthy subjects. Overall, we observed no sex differences in the
changes of plasma concentrations of fatty acid derivatives. How-
ever, the POEA concentrations were found to be altered exclusively
in women diagnosed with lifetime cocaine use disorders. Our
current data show that plasma POEA was markedly increased in
abstinent cocaine-addicted women, and similar changes have been
previously observed in another study with cocaine addicts who
were diagnosed with comorbid mood or anxiety disorders (19).
Little is known about POEA, but it has been suggested that it regu-
lates appetite and energy metabolism through a non-cannabinoid
receptor (46, 47). Interestingly, palmitoleate is the fatty acid from
which POEA is derived, and the former has been suggested to be
a lipokine associated with metabolic abnormalities (48). In fact,
we observed a significant effect of BMI on POEA concentrations
of our sample, and this influence stayed with the cocaine group.
However, there are no data related to the role of POEA in psy-
chopathologies and addiction. In the present study, we did not
observe relationships between POEA concentrations and variables
related cocaine addiction such as length of abstinence, cocaine
symptom severity, or diagnosis of comorbid psychopathologies,
but sex was strongly associated with POEA in cocaine-addicted
subjects. Although the small number of cocaine-addicted women
does not allow for a conclusion of the impact of comorbid mental
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disorders on POEA concentrations, we must note that female
addicts have a higher prevalence of psychiatric comorbidity than
do men.
The associations between circulating endocannabinoids and
mental disorders have been extensively studied in clinical stud-
ies, and a common observation found in these disorders is the
elevated concentrations of N -acyl-ethanolamines (49–51). Fur-
ther, increased N -acyl-ethanolamine concentrations have been
observed in psychiatric patients with substance use disorders,
such as in schizophrenia patients (40). Accordingly, we observed
a significant relationship between SEA and diagnosis of comor-
bid psychiatric disorders in cocaine-addicted subjects, with higher
concentrations in comorbid addicts. However, classical endo-
cannabinoids such as AEA and 2-AG were not influenced by
comorbidity.
LIMITATIONS AND FUTURE PERSPECTIVES
Our findings support the importance of monitoring these puta-
tive predictors in the context of a history of cocaine addiction by
accounting for both sex differences and psychiatric comorbidity.
We are aware of the limitations of the current study. First, the
number of cocaine-addicted women is small, and replicating these
data with a larger sample will be necessary to confirm the sexual
dimorphism observed in the present study, primarily in plasma
cytokines and POEA. Second, we must determine whether these
alterations in cocaine-addicted women are exclusively attributable
to sex or to comorbid psychiatric disorders. Therefore, new stud-
ies in female psychiatric patients with no history of drug abuse
will be necessary to elucidate the influence of mental disorders in
these circulating predictors of cocaine addiction. Related to these
mentioned limitations, women were randomly recruited without
considering the menstrual cycle, and this condition should be
considered in future studies including cocaine-addicted women.
Third, with regard to the cocaine use effect, we are unaware of
the effects on the plasma concentrations of these molecules in
active cocaine users because the presence of cocaine can induce
prolonged activation, and the present data were obtained from
subjects with a history of addiction. Animal models can be a use-
ful tool to perform future investigations for responding to these
questions. Finally, the recruitment of abstinent cocaine-addicted
subjects under treatments in centers for addiction was performed
on an outpatient basis; consequently, medications as well as social
and environmental factors must be considered.
In summary, whereas the plasma concentrations of inflam-
matory and fatty acid-derived mediators may allow for a better
stratification of cocaine addicts, the sexual dimorphism must also
be considered for the adequate selection of biomarkers for cocaine
addiction and therapeutic purposes.
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